B. Caner et al., EFFECT OF AN ADDITIONAL ATROPINE INJECTION DURING DOBUTAMINE INFUSIONFOR MYOCARDIAL SPET, Nuclear medicine communications, 18(6), 1997, pp. 567-573
The aim of this study was to examine the value of an additional atropi
ne injection in patients who do not achieve an adequate heart rate dur
ing dobutamine infusion for myocardial perfusion SPET (single photon e
mission tomography). Patients undergoing dobutamine myocardial SPET wh
o failed to achieve greater than or equal to 85% of their age-predicte
d maximal heart rate at the end of dobutamine infusion (D protocol) ha
d a second dobutamine myocardial SPET study on a separate day with the
addition of an atropine injection during the dobutamine infusion (D A protocol). Twenty-nine patients were studied. Tl-201 was used in 27
patients and Tc-99(m)-MIBI in two patients. All patients underwent co
ronary angiography and significant coronary artery disease was found i
n 19 of 29 patients. The mean heart rate obtained at the peak of dobut
amine infusion in the D+A protocol was significantly higher than that
in the D protocol (153.8 +/- 13.8 vs 117.5 +/- 15.3 beats min(-1)). Th
e D + A protocol resulted in a higher diagnostic sensitivity for the d
etection of stenosed coronaries compared with the D protocol (87 vs 80
%, P > 0.05) without changing the specificity (89% for both protocols)
. On the other hand, the frequency of side-effects and ECG changes dur
ing the D + A protocol was higher than that with the D protocol (32 vs
47). In conclusion, the addition of an atropine injection during dobu
tamine infusion resulted in a higher diagnostic sensitivity for identi
fying stenosed coronaries compared to dobutamine alone.